| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Salkind Gene is a Director, 10% Owner at MOBQ, with reported holdings spanning 3 companies. Recent filings cover 6 purchases and 0 sales. Those positions are worth an estimated $8.9M at current prices.
Our model assigns Salkind Gene a below-average insider score of 24/100, based on 3 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -73.5%.
Salkind Gene's largest disclosed position is in MOBQ as Director, 10% Owner, worth about $8.7M. Net of sales, the recent Form 4 record there shows accumulation of 175,000,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2024 | COEP Coeptis Therapeutics Holdings, Inc. | Director | Buy | 11,600 | $0.69 | $8,004.00 | +4.3% | -52.4% | -58.7% | |
| Aug 29, 2023 | COEP Coeptis Therapeutics Holdings, Inc. | - | Buy | 32,644 | $0.92 | $30,106.64 | -114.1% | +8.4% | -81.8% | |
| Sep 13, 2019 | MOBQ Mobiquity Technologies, Inc. | Director, 10% Owner | Buy | 175,000,000 | $0.02 | $3,194,750.00 | +191.6% | - | - |